<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112443876</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112443876</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Expression and Functionality of Transient Receptor Potential Vanilloid 1 in Ovarian Endometriomas</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jiangang</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112443876">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xishi</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112443876">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duan</surname>
<given-names>Kaizheng</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112443876">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuqiu</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112443876">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Sun-Wei</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112443876">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719112443876"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112443876">
<label>1</label>Shanghai OB/GYN Hospital, Fudan University, Shanghai, China</aff>
<aff id="aff2-1933719112443876">
<label>2</label>State Key Laboratory of Medical Neurobiology and Institute of Brain Science, Fudan University, Shanghai, China</aff>
<author-notes>
<corresp id="corresp1-1933719112443876">Sun-Wei Guo, Ph.D. Shanghai Obstetrics and Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai 200011, China Email: <email>hoxa10@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>10</issue>
<fpage>1110</fpage>
<lpage>1124</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>Pains of various kinds—dysmenorrhea, chronic pelvic pain, and dyspareunia—are the major complaints from women with endometriosis, representing the most debilitating nature of the disease. Despite extensive research, our understanding as how endometriosis causes pain is still fragmentary. In this study, we examined transient receptor potential vanilloid 1 (TRPV1)-positive nerve fibers in ectopic endometrium from women with ovarian endometriomas and in endometrium from women without endometriosis and correlated the density with the severity of dysmenorrhea in cases. We also performed an immunohistochemistry analysis of TRPV1 in ectopic and control endometrium. After finding TRPV1 immunoreactivity in ectopic endometrial cells, we further examined whether TRPV1 is functional in ectopic endometrial stromal cells (EESCs). We found that the density of TRPV1-positive nerve fibers in ectopic endometrial implants is higher than that in control endometrium and correlates positively with the severity of dysmenorrhea in women with endometriosis. In addition, TRPV1 expression was also found to be elevated significantly in EESCs when stimulated with inflammatory mediators such as prostaglandin E2 (PGE<sub>2</sub> ) and tumor necrosis factor-α (TNF-α). Finally, we found that TRPV1 activation can induce the release of nitric oxide (NO) and interleukin 1β (IL-1β) in EESCs. The latter finding appears to be consistent with the reports of increased TRPV1 protein expression following peripheral inflammation. Our results suggest that the increased TRPV1-positive nerve fibers may integrate various stimuli on peripheral terminals or primary sensory neurons and generate hyperalgesia in endometriosis. The expression and functionality of TRPV1 in EESCs also suggest that TRPV1 may have neurosecretory functions that are yet to be elucidated.</p>
</abstract>
<kwd-group>
<kwd>endometriosis</kwd>
<kwd>capsaicin</kwd>
<kwd>Ca<sup>2+</sup>
</kwd>
<kwd>dysmenorrhea</kwd>
<kwd>TRPV1</kwd>
<kwd>inflammation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112443876">
<title>Introduction</title>
<p>Pains of various kinds—dysmenorrhea, chronic pelvic pain, and dyspareunia—are the major complaints from women with endometriosis, representing the most debilitating nature of the disease.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112443876">1</xref>,<xref ref-type="bibr" rid="bibr2-1933719112443876">2</xref>
</sup> Consequently, in treating women with endometriosis, one primary goal is to alleviate pain. Despite extensive research, our understanding as to how endometriosis causes pain is still fragmentary. In the last decade, there is a growing interest in the investigation of endometriosis-associated pain.</p>
<p>Anaf et al reported a close histological relationship between nerve density in rectovaginal endometriotic nodules<sup><xref ref-type="bibr" rid="bibr3-1933719112443876">3</xref></sup> and also a role of nerve infiltration and nerve growth factor (NGF) expression in deep adenomyotic nodules.<sup>
<xref ref-type="bibr" rid="bibr4-1933719112443876">4</xref>
</sup> Berkley et al demonstrated in a rat model of endometriosis that endometriotic lesions induce an autonomic and sensory innervation, thus contributing to pain symptoms associated with endometriosis.<sup>
<xref ref-type="bibr" rid="bibr5-1933719112443876">5</xref>,<xref ref-type="bibr" rid="bibr6-1933719112443876">6</xref>
</sup> In peritoneal endometriosis, several groups have reported that the density of nerve fibers is increased in lesions,<sup>
<xref ref-type="bibr" rid="bibr7-1933719112443876">7</xref>
</sup> which often is associated with pain<sup><xref ref-type="bibr" rid="bibr8-1933719112443876">8</xref>,<xref ref-type="bibr" rid="bibr9-1933719112443876">9</xref>
</sup> and is reduced after hormonal treatment.<sup>
<xref ref-type="bibr" rid="bibr10-1933719112443876">10</xref>
</sup> In deep infiltrating endometriosis which is associated more often with pelvic pains than other subtypes of endometriosis, the number and/or density of nerve fibers is also increased,<sup>
<xref ref-type="bibr" rid="bibr11-1933719112443876">11</xref>
</sup> which is higher than that in other subtypes.<sup>
<xref ref-type="bibr" rid="bibr12-1933719112443876">12</xref>,<xref ref-type="bibr" rid="bibr13-1933719112443876">13</xref>
</sup> Similarly, ovarian endometriomas are found to be innervated mainly by sympathetic and sensory fibers,<sup>
<xref ref-type="bibr" rid="bibr14-1933719112443876">14</xref>
</sup> and the nerve fiber density is shown to be higher in women with pain than in women without pain.<sup>
<xref ref-type="bibr" rid="bibr15-1933719112443876">15</xref>
</sup>
</p>
<p>In all these published studies, the afferent nerve fibers are Aδ or C type stained by various markers such as S-100, calcitonin gene-related peptide (CGRP), substance P (SP), protein gene product 9.5 (PGP9.5), neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), neurofilament (NF), acetylcholine (ACh), tyrosine hydroxylase (TH) NGF, and its receptors tyrosine kinase receptor A (TrkA) and p75. Interestingly, no report on the use of transient receptor potential vanilloid 1 (TRPV1) in staining afferent nerve fibers has been published.</p>
<p>The capsaicin (CAP) receptor TRPV1 is a member of the transient receptor potential vanilloid family consisting of 7 members, TRPV1 to TRPV7. As a nonselective cation channel, TRPV1 is expressed by sensory neurons and responds to noxious heat (&gt;43°C), acid (pH &lt;5.9), protons, vanilloids, and various endogenous ligands. TRPV1 activity is enhanced by various inflammatory mediators such as NGF, somatostatin, bradykinin, prostaglandins, serotonin, and others, implicating an essential role of TRPV1 in integrating different signal pathways for mediating nociceptor sensitization.<sup>
<xref ref-type="bibr" rid="bibr16-1933719112443876">16</xref>
</sup> TRPV1 has been shown to play a role in inflammatory hyperalgesia in animal models.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112443876">17</xref>
</sup> Inflammation-induced ongoing pain is shown to be driven by TRPV1-sensitive afferents.<sup>
<xref ref-type="bibr" rid="bibr18-1933719112443876">18</xref>
</sup> TRPV1 is synthesized in sensory neurons in the dorsal root ganglia (DRG) and transported along their peripheral axons to both peripheral and viscera and centrally to the spinal dorsal horn. Activation of TRPV1 also leads to local release of sensory neuropeptides including CGRP and SP, which, in turn, activate their effector cell receptors and contribute to the process of neurogenic inflammation. TRPV1 also is expressed in nonsensory cells, although its significance is currently unclear.</p>
<p>In women with endometriosis, TRPV1 immunoreactivity is shown to be elevated in peritoneal endometriotic foci and is correlated with the presence of chronic pelvic pain.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112443876">19</xref>
</sup> In a mouse model of endometriosis, the induction of endometriosis resulted in increased immunoreactivity to TRPV1 in eutopic endometrium, but treatment with a histone deacetylase inhibitor reduced the TRPV1 staining, along with improved tolerance to noxious thermal stimulation.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112443876">20</xref>
</sup> In adenomyosis, TRPV1 staining is significantly increased in ectopic endometrium as compared with normal endometrium. In fact, TRPV1 immunoreactivity is found to be positively correlated with the severity of dysmenorrhea.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112443876">21</xref>
</sup> While the significance of TRPV1 expression in nonsensory cells in endometriosis remains unclear, it is not known whether TRPV1 is functional.</p>
<p>In this study, we examined TRPV1-positive nerve fibers in ectopic endometrium in cases and normal endometrium in controls and correlated the density with the severity of dysmenorrhea in cases. We also carried out an immunohistochemistry (IHC) analysis of TRPV1 in ectopic and normal endometrium. After finding TRPV1 immunoreactivity in ectopic endometrial stromal cells (EESCs) and epithelial cells, we examined whether prostaglandin E2 (PGE<sub>2</sub> ) and tumor necrosis factor-α (TNF-α) stimulation can induce TRPV1 expression in primary endometriotic stromal cells and whether CAP can increase intracellular calcium concentration and evoke membrane currents. Finally, we examined whether TRPV1 activation can induce the release of nitric oxide (NO) and interleukin 1β (IL-1β) in these cells. The purpose of this study was severalfold: to correlate TRPV1-positive nerve fiber density with the severity of dysmenorrhea, to identify the localization of TRPV1 in ectopic endometrial implants, and to examine whether it is functional or not in nonneuronal cells in ovarian endometriomas.</p>
</sec>
<sec id="section2-1933719112443876" sec-type="materials|methods">
<title>Methods and Materials</title>
<sec id="section3-1933719112443876">
<title>Patients and IHC</title>
<p>Sixty-three patients with ovarian endometriomas were included for this study. These patients underwent conservative or semiradical surgery via either laparotomy or laparoscopy at Shanghai OB/GYN Hospital, Fudan University from 2008 to 2009. All diagnoses were confirmed histologically by experienced pathologists. Patients concurrent with adenomyosis were excluded. For each patient, information was collected through reading medical charts and interviewing patients on age at surgery, severity of dysmenorrhea, presence of myoma, if any, laterality of endometrioma, size of endometrioma (defined to be the diameter in centimeter of the largest cyst), the Revised American Fertility Society Classification of Endometriosis (rAFS) scores and stage, and the menstrual phase during which the surgery was performed. As a custom, the severity of pain was quantified by verbal descriptor scale, as none, mild, moderate, or severe. For controls, we collected, after informed consent, endometrial tissue samples through curettage from 24 women with tubal infertility or surgically diagnosed benign ovarian cysts but without any clinical history or diagnosis of endometriosis, adenomyosis, or myoma. None of the controls complained dysmenorrhea or other forms of pelvic pain. The selection of the controls was based solely on menstrual phase and age besides disease status. This study was approved by the institutional ethics review board of Shanghai OB/GYN Hospital.</p>
<p>Serial 4-μm sections were obtained from each block, with the first resultant slide being stained with hematoxylin and eosin (H&amp;E) to confirm pathologic diagnosis, and the subsequent slides stained for polyclonal rabbit anti-TRPV1 antibody (ab63083, diluted at 1:300, Abcam, Cambridge, UK). Routine deparaffinization and rehydration procedures were performed. For antigen retrieval, the slides were heated at 98°C in an EDTA buffer (pH 9.0) for a total of 30 minutes and cooled naturally to the room temperature. Endogenous peroxidase was blocked by incubation in 0.3% weight/volume (w/v) hydrogen peroxide in methanol. After rehydration in phosphate-buffered saline (PBS), sections were then incubated with the primary antibody overnight at 4°C. After the slides were rinsed, the horseradish peroxixdase (HRP)-labeled secondary antibody Supervision TM Universal (Anti-Mouse/Rabbit) Detection Reagent (Shanghai Gene Tech Company, Shanghai; Cat No: GK500705) was incubated at room temperature for 30 minutes. The bound antibody complexes were stained for 3 to 5 minutes or until appropriate for microscopic examination with diaminobenzidine and then counterstained with hematoxylin and mounted. To further identify the TRPV1 immunoreactive nerve fibers, the frozen sections were stained again with indirect immunofluorescence method with a secondary antibody of goat TRITC anti-rabbit antibody (1:100, Beckman, Urbana, Illinois), counterstained with 4',6-diamidino-2-phenylindole (DAPI) and then were covered with a coverslip.</p>
<p>Each staining run incorporated a positive control slide from the DRG and mouse. A negative control was obtained using preimmune immunoglobulin G (IgG) instead of the primary antibody. Immunoreactive staining was characterized quantitatively by digital image analysis using the Image Pro-Plus 6.0 (Media Cybernetics, Inc, Bethesda, MD, USA) as reported in Wang-Tilz et al,<sup><xref ref-type="bibr" rid="bibr22-1933719112443876">22</xref></sup> without prior knowledge of any of the clinicopathological information of the patients being evaluated.</p>
<p>The procedure of microvascular density quantification as described by Weidner et al<sup><xref ref-type="bibr" rid="bibr23-1933719112443876">23</xref></sup> was used to count the number of TRPV1 immunoreactive nerve fibers in ectopic endometrial lesions. The entire section was scanned at low power (×100) to identify hot spots, which represent the areas of highest innervation followed by nerve fiber counting on 5 randomly chosen fields (×200) of the “hot spots” by the same investigator without any knowledge of the pain status of the patient being evaluated. The total number of nerve fibers was divided by the total number of hot spots on each section to obtain an average of nerve fibers per hot spot (∼1 mm<sup>2</sup> per spot). The results were expressed as the mean (±SD) number of nerve fibers per mm<sup>2</sup> in each specimen.</p>
</sec>
<sec id="section4-1933719112443876">
<title>Tissue Collection, Cell Preparation, Culture, and Reagents</title>
<p>The isolation and culturing of primary ESCs were carried out as previously described.<sup>
<xref ref-type="bibr" rid="bibr24-1933719112443876">24</xref>
</sup> Briefly, normal primary ESCs were isolated from endometrial biopsies obtained from either controls (normal ESCs [NESCs]) or linings of ovarian endometrioma cyst (EESCs). The tissues were minced into 1-mm<sup>2</sup> fragments with sterile scissors and the isolation of the stromal cells was conducted by digesting endometrial fragments with 0.25% type I collagenase for 30 minutes in a shaking water bath at 37°C. The digestate was filtered through a 38-µm stainless steel sieve to remove the glands. Purification of the stromal cell-enriched fraction was accomplished with a Percoll gradient and incubated for 30 minutes at 37°C in a standard humidified 95% air/5% CO<sub>2</sub> incubator. During this period, the ESC, but not the other cell types, were attached to polystyrene tissue culture plastic. The ESCs were grown in the DMEM/F12 (GIBCO, GrandIsland, New York) containing 10% fetal bovine serum (PAA Laboratories, Linz, Austria) and 10% penicillin/streptomycin (Invitrogen, Lofer, Austria). Before drug treatment, phenol red-free DMEM/F12 medium was replenished. Anti-TRPV1 rabbit polyclonal antibody was purchased from Abcam (ab63083, Cambridge, UK). Capsaicin, capsazepine (CZP), PGE<sub>2</sub>, and TNF-α were purchased from Sigma (St Louis, MO, USA).</p>
</sec>
<sec id="section5-1933719112443876">
<title>RNA Isolation, Quantitative Real-Time Polymerase Chain Reaction</title>
<p>The total RNA was extracted from treated and untreated cells with Trizol reagent (Invitrogen) following the manufacturer’s instructions. The RNA preparation was then treated with Dnase1 (Invitrogen) and 1 μg RNA was reverse transcribed into complementary DNA (cDNA) with a reverse transcription kit (Takara, Shuzo, Kyoto, Japan). Real-time polymerase chain reaction (PCR) analysis was conducted using the Applied Biosystems 7000 Sequence Detection System (Foster City, California) equipped with a 96-well optical reaction plate. The PCRs were set up using 10 μL SYBR Green PCR Master Mix (Takara), 0.8 μL of 10 μmol/L primer mixture, and 2 μL cDNA template. The real-time PCR conditions were as follows: 95°C for 30 seconds followed by 35 cycles at 95°C for 5 seconds, and 60°C for 31 seconds. The primers used in the present study were as follows: TRPV1: forward primer 5’-CAG CAG CGAGAC CCC TAA-3’, reverse primer 5-ACT TGG CTG AGGACG TCC-3; glyceraldehyde 3-phosphate dehydrogenase (GAPDH): forward primer 5’GGCATG GAC TGT GGT CAT GA-3’, reverse primer 5’-TGCACCACCAACTGCTTAGC-3’. All real-time PCR experiments were carried out in triplicate, and a mean value was used for the determination of messenger RNA (mRNA) expression levels. A negative control containing water instead of sample cDNA was applied to each real-time plate. At the end of the PCR run, the threshold value (C<sub>T</sub> ) for each of these genes was set using the ABI PRISM 7000 software program (Applied Biosystems, Foster City, CA, USA). The relative expression of mRNA was calculated using the comparative C<sub>T</sub> method.</p>
</sec>
<sec id="section6-1933719112443876">
<title>Western Blot Analysis</title>
<p>The cultured primary NESCs and EESCs, treated or untreated, were rinsed 3 times with cold PBS and then harvested by a cell scraper. The cells were lysed with complete lysis-M buffer (Roche, Nutley, New Jersey). The homogenates were then spun at 12 000<italic>g</italic> for 30 minutes and the supernatants were determined using the bicinchoninic acid (BCA) method. Protein samples (30 μg) were loaded onto an 8% sodium dodecyl sulfate–polyacrylamide gel, electrophoresed, and then transferred to a polyvinylidene difluoride (PVDF) membrane. Afterward the blotting membranes were blocked with PBST (PBS/0.1%Tween-20) (80 mmol/L Na<sub>2</sub> HPO<sub>4</sub>, 20 mmol/L NaH<sub>2</sub> PO<sub>4</sub>, 100 mmol/L NaCl, 0.1% Tween 20, pH 7.5) plus 5% nonfat milk and incubated overnight with the primary antibody at 4°C. After washing, the blots were incubated in HRP-conjugated secondary antibody for 1 hour at room temperature. The blots were detected with the chemiluminiscence reagent (SuperSignal West Pico, Rockford, Illinois).</p>
</sec>
<sec id="section7-1933719112443876">
<title>Patch Clamp Electrophysiology</title>
<p>The cultured primary EESCs selected for recordings were within 2 to 4 passages, and the resting membrane potential was found to be more negative than −60 mV. The patch electrodes with a resistance of 2 to 5 MΩ were pulled from borosilicate glass capillaries (the inner diameter (ID) ID = 0.86 mm, outer diameter (OD) OD = 1.5 mm, Sutter Instruments, Novato, California) using a micropipette puller (P-97, Sutter Instruments). Whole-cell patch clamp recordings were carried out using an Axonpatch 200B amplifier (Axon Instruments, Union City, California). After the whole-cell configuration was established, the cell membrane capacitance and series resistance were compensated (&gt;80%). The leak currents were subtracted using the online P/4 protocol. All experiments were performed at room temperature (about 25°C). Signals were filtered at 2 kHz and digitized at 10 kHz. For the whole-cell recording, the pipette solution contained the following (in mmol/L): KCl 150, MgCl<sub>2</sub> 2.5, N-2-hydroxyethylpiperazine-N-2′-ethanesulfonic acid (HEPES) 10, Ethylene glycol-bis-(,8- aminoethylether)N,N,N′,N′-tetraacetic acid (EGTA) 0.2, MgATP 2, and Na<sub>2</sub>GTP 0.3 (pH adjusted to 7.4 with KOH). The external solution contained NaCl (150 mmol/L), KCl (5 mmol/L), CaCl<sub>2</sub> (2 mmol/L), MgCl<sub>2</sub> (1 mmol/L), HEPES (10 mmol/L), and glucose (10 mmol/L), and the pH adjusted to 7.4 with NaOH. Throughout the experiment, the drug solution was delivered to the cells via a fast perfusion system (ALA-VM8, Scientific Instrument Inc, Westbury, New York). The distance between the cells and the silicon barrel tip (OD/ID = 200/100 μm) was ∼200 μm. Inhibitors were applied to the chamber for 30 minutes before the addition of CAP. Data were presented as the mean ± standard error of the mean (SEM) or as numerical values ± SE, with <italic>n</italic> indicating the number of cells in a given series of experiments. Data were analyzed using the Clampfit 10.2 software (Axon Instruments).</p>
</sec>
<sec id="section8-1933719112443876">
<title>Measurement of Intracellular Calcium</title>
<p>The cultured primary ESCs were grown to 70% to 80% confluency and then washed with Ringer solution that had the following composition: 140 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L CaCl<sub>2</sub>, 1 mmol/L MgCl<sub>2</sub>, 10 mmol/L HEPES, and 10 mmol/L glucose, adjusted to pH = 7.4 with NaOH. Cells were loaded with the calcium-sensitive indicator fluo3/acetoxymethyl ester (fluo-3/AM, Molecular Probes, Inc; Cat# F1241, Carlsbad, California) at a concentration of 5 μmol/L in Ringer solution for 60 minutes. The Fluo-3/AM was diluted from a concentrated stock solution (1 mmol/L) dissolved in dimethyl sulfoxide (DMSO). After loading, the cells were washed 3 times with Ringer solution and then placed in a recording chamber and were then superfused with Ringer solution. The calcium image was recorded by a confocal laser scanning microscope (Leica TCS-NT, Heidelberg, Germany). The intracellular Ca<sup>2+</sup> level was represented by the fluo3 fluorescence intensity. Fluo3 fluorescence was excited at 488 nm, and the emitted light was measured at 530 nm. Fluorescent intensity readings were made at 3-second intervals following the addition of an agonist to the cells. The peak increase in relative fluorescent units (RFUs) over the baseline fluorescence (ΔF/F<sub>0</sub>) was calculated and analyzed with TCS-NT software (Leica).</p>
</sec>
<sec id="section9-1933719112443876">
<title>Measurement of Nitrite/Nitrate and IL-1β Production</title>
<p>The cultured primary EESCs were inoculated in 6-well plates at a concentration of 5 × 10<sup><xref ref-type="bibr" rid="bibr5-1933719112443876">5</xref></sup> cells/mL and a total volume of 1 mL. At 24 hours after culture, the culture medium without serum was replaced and these cells were starved for 12 hours and then stimulated for 24 hours. A NO colorimetric assay kit (#k262, BioVision, California) was used to measure total gas phase NO (nitrite/nitrate) in the culture medium according to the vendor’s instructions. Briefly, NO was rapidly oxidized to nitrite and nitrate which were used to quantitate the NO production. This kit provides an accurate and convenient measure of total nitrate/nitrite in a simple 2-step process. The first step converts nitrate into nitrite using nitrate reductase. The second step uses Griess reagents to convert nitrite into a deep purple azo compound. The amount of the azo chromophore accurately reflects the NO amount in the sample. The medium was collected 24 hours after drug treatment, the amount of IL-1β was measured using a Quantikine IL-1β ELISA kit (Shanghai Jitai Biotech Company, Shanghai, China). After removing the media, cells were typsinized and counted to normalize for cell density.</p>
</sec>
<sec id="section10-1933719112443876">
<title>Statistical Analysis</title>
<p>The comparison of distributions of continuous variables between 2 or more groups was made using the Wilcoxon or Kruskal test, respectively, and the paired Wilcoxon test was used when the before–after comparison was made for the same group of participants. Pearson or Spearman rank correlation coefficient was used when evaluating the correlations between 2 variables when both variables are continuous or when at least 1 variable is ordinal.</p>
<p>Jonckheere trend test was used to test whether there is any association between the severity of pelvic pain and other factors of interest. To evaluate the factors that are associated with the severity of dysmenorrhea, we used the Cox regression model for the discrete or grouped survival time data without censoring.<sup>
<xref ref-type="bibr" rid="bibr25-1933719112443876">25</xref>
</sup> The severity of dysmenorrhea was coded as 0 for <italic>none</italic>, 1 for <italic>mild</italic>, 2 for <italic>moderate</italic>, and 3 for <italic>severe</italic>.</p>
<p>
<italic>P</italic> values of less than .05 were considered statistically significant. All computations were made with R 2.13.1 (www.r-project.org).<sup><xref ref-type="bibr" rid="bibr26-1933719112443876">26</xref></sup>
</p>
</sec>
</sec>
<sec id="section11-1933719112443876">
<title>Results</title>
<sec id="section12-1933719112443876">
<title>Patients</title>
<p>The characteristics and the 63 patients with ovarian endometriomas (cases) and 24 controls were listed in <xref ref-type="table" rid="table1-1933719112443876">Table 1</xref>. It can be seen that the 2 groups were comparable with respect to age and menstrual phase at which the tissue samples were harvested.</p>
<table-wrap id="table1-1933719112443876" position="float">
<label>Table 1.</label>
<caption>
<p>Characteristics of Cases and Controls</p>
</caption>
<graphic alternate-form-of="table1-1933719112443876" xlink:href="10.1177_1933719112443876-table1.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>Women With Endometriosis (n = 63)</th>
<th>Women Without Endometriosis (n = 24)</th>
<th>Statistical Significance of the Difference Between the 2 Groups</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age in years (mean ± SD, range)</td>
<td>35.0 ± 6.7 (22-53)</td>
<td>36.8 ± 4.9 (29-45)</td>
<td align="center">.10</td>
</tr>
<tr>
<td colspan="4">revised American Fertility Society (rAFS) stage</td>
</tr>
<tr>
<td> III</td>
<td>46 (73%)</td>
<td align="center">NA<sup>a</sup>
</td>
<td align="center">NA</td>
</tr>
<tr>
<td> IV</td>
<td>17 (27%) </td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td colspan="4">Type of pelvic pain</td>
</tr>
<tr>
<td> Dysmenorrhea (Dys)</td>
<td>33 (52.4%)</td>
<td align="center">NA</td>
<td align="center">NA</td>
</tr>
<tr>
<td> chronic pelvic pain (CPP) + Dys</td>
<td>11 (17.5%)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td colspan="4">Severity of pain</td>
</tr>
<tr>
<td> None</td>
<td>19 (30.2%)</td>
<td>24 (100%)</td>
<td>
</td>
</tr>
<tr>
<td> Mild</td>
<td>22 (35.0%)</td>
<td>
</td>
<td align="center">NA</td>
</tr>
<tr>
<td> Moderate</td>
<td>14 (22.2%)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Severe</td>
<td>8 (12.7%)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td colspan="4">Menstrual phase</td>
</tr>
<tr>
<td> Proliferative phase</td>
<td>34 (54.0%)</td>
<td>14 (58.3%)</td>
<td align="center">.81 (Fisher exact test)</td>
</tr>
<tr>
<td> Secretory phase</td>
<td>29 (41.3%)</td>
<td>10 (41.7%)</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112443876">
<p>Abbreviations: NA, not applicable; SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section13-1933719112443876">
<title>TRPV1 IHC in Ectopic and Normal Endometrium</title>
<p>TRPV1 staining in normal and ectopic endometrium was seen mostly in cytoplasm (<xref ref-type="fig" rid="fig1-1933719112443876">Figure 1</xref>). While TRPV1 staining levels in epithelium and stroma were highly correlated (<italic>r</italic> = .97, <italic>P</italic> = 3.6 × 10<sup>−15</sup>, and <italic>r</italic> = .60, <italic>P</italic> = 1.6 × 10<sup>−7</sup>, in control and ectopic endometrium, respectively), the immunoreactivity to TRPV1 was significantly higher in epithelium than stroma in both normal and ectopic endometrium (<italic>P</italic> = 2.4 × 10<sup>−7</sup> and <italic>P</italic> = 4.2 × 10<sup>−11</sup>, respectively), consistent with a previous report.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112443876">19</xref>
</sup> There was no difference in TRPV1 staining in either normal endometrium or ectopic endometrium with respect to menstrual phase, irrespective of cell types (all 4 <italic>P</italic> values &gt;.66).</p>
<fig id="fig1-1933719112443876" position="float">
<label>Figure 1.</label>
<caption>
<p>Immunohistochemical staining of transient receptor potential vanilloid 1 (TRPV1) in ectopic and normal endometrium. A, Negative control using preimmune serum instead of the primary antibody. B, Staining in an ectopic endometrial tissue. C, Positive control: staining in DRG of rat (×400). D, Staining in normal endometrium. Magnification: ×200 unless otherwise indicated.</p>
</caption>
<graphic alternate-form-of="fig1-1933719112443876" xlink:href="10.1177_1933719112443876-fig1.tif"/>
</fig>
<p>The TRPV1 staining was significantly higher in ectopic endometrium than that in normal endometrium in both epithelial and stromal components (<italic>P</italic> = 2.2 × 10<sup>−8</sup> and <italic>P</italic> = 2.6 × 10<sup>−5</sup>, respectively; <xref ref-type="fig" rid="fig2-1933719112443876">Figure 2A</xref> and <xref ref-type="fig" rid="fig2-1933719112443876">B</xref>). Among women with endometriosis, the TRPV1 staining levels in stromal cells, but not in epithelial cells, in ectopic endometrium was associated with the severity of dysmenorrhea (<italic>P</italic> = .027 and <italic>P</italic> = .15 for stroma and epithelium, respectively, by the Jonckheere trend test). In fact, there was a positive correlation between the severity of pain and TRPV1 staining levels in stromal, but not epithelial, cells (Spearman <italic>r</italic> = .29, <italic>P</italic> = .023 for stromal cells and <italic>r</italic> = .20, <italic>P</italic> = .12 for epithelial cells; <xref ref-type="fig" rid="fig2-1933719112443876">Figure 2C</xref> and <xref ref-type="fig" rid="fig2-1933719112443876">D</xref>). There was a statistically significant difference in TRPV1 staining levels in both stromal and epithelial cells between women who complained of dysmenorrhea and who did not (<italic>p</italic> = 0.004 and <italic>p</italic> = 0.02, respectively).</p>
<fig id="fig2-1933719112443876" position="float">
<label>Figure 2.</label>
<caption>
<p>Box plots of transient receptor potential vanilloid 1 (TRPV1) staining levels in different cell types by tissue group. A, Stroma component. B, Epithelium component. C, Ectopic endometrial stromal component. D, Ectopic endometrial epithelial component.</p>
</caption>
<graphic alternate-form-of="fig2-1933719112443876" xlink:href="10.1177_1933719112443876-fig2.tif"/>
</fig>
</sec>
<sec id="section14-1933719112443876">
<title>Correlation of Dysmenorrhea Severity and the TRPV1-Positive Nerve Fiber Density</title>
<p>We found that the severity of dysmenorrhea correlated positively with the size of ovarian cysts (Spearman <italic>r</italic> = .29, <italic>p</italic> = .021; <italic>p</italic> = .021 also using Jonckheere trend test) but not rAFS scores or stage (<italic>r</italic> = .01, <italic>P</italic> = .95 and <italic>r</italic> = −.05, <italic>P</italic> = .71). Laterality of the ovarian cysts did not correlate with pain severity (<italic>P</italic> = .72).</p>
<p>We also found TRPV1-positive nerve fibers in and/or surrounding the endometriotic lesions (<xref ref-type="fig" rid="fig3-1933719112443876">Figure 3</xref>). <xref ref-type="table" rid="table2-1933719112443876">Table 2</xref> showed the percentage and mean density of TRPV1-positive nerve fibers in lesions in women with various severity of dysmenorrhea. TRPV1-positive nerve fibers were rarely found in normal endometrium (data not shown). In sharp contrast, they were found surrounding ectopic endometrium, and the density of TRPV1-positive nerve fibers was found to be positively associated with the severity of dysmenorrhea (<italic>P</italic> = .002, Jonckheere trend test; <xref ref-type="table" rid="table2-1933719112443876">Table 2</xref> and <xref ref-type="fig" rid="fig4-1933719112443876">Figure 4</xref>). In fact, the density of TRPV1-positive nerve fibers surrounding endometriotic lesions correlated positively with the severity of dysmenorrhea (Spearman <italic>r</italic> = .42, <italic>P</italic> = .0007; <xref ref-type="fig" rid="fig4-1933719112443876">Figure 4</xref>). The nerve fiber density did not correlate with either rAFS score or rAFS stage (<italic>r</italic> = .03, <italic>P</italic> = .80, and Spearman <italic>r</italic> = .17, <italic>P</italic> = .20, respectively).</p>
<fig id="fig3-1933719112443876" position="float">
<label>Figure 3.</label>
<caption>
<p>Transient receptor potential vanilloid 1 (TRPV1)-positive nerve fibers surrounding the endometriotic lesions. A, The arrows indicate nerve fibers near the ectopic glandular epithelium. The truncated arrow indicates ectopic glandular epithelium. B, TRPV1-positive nerve fibers in the fibrotic interstitial of ectopic endometrium. Magnification: ×200.</p>
</caption>
<graphic alternate-form-of="fig3-1933719112443876" xlink:href="10.1177_1933719112443876-fig3.tif"/>
</fig>
<fig id="fig4-1933719112443876" position="float">
<label>Figure 4.</label>
<caption>
<p>Box plot of the density of TRPV1-positive nerve fibers surrounding endometriotic lesions in women with different severity of dysmenorrhea.</p>
</caption>
<graphic alternate-form-of="fig4-1933719112443876" xlink:href="10.1177_1933719112443876-fig4.tif"/>
</fig>
<table-wrap id="table2-1933719112443876" position="float">
<label>Table 2.</label>
<caption>
<p>The Percentage and Density of TRPV1 Immunoreactive Nerve Fibers in Ectopic Endometrium of Women With Endometriosis</p>
</caption>
<graphic alternate-form-of="table2-1933719112443876" xlink:href="10.1177_1933719112443876-table2.tif"/>
<table>
<thead>
<tr>
<th rowspan="2">Severity of Pelvic Pain</th>
<th rowspan="2">Cases (n)</th>
<th colspan="2">TRPV1-Positive Nerve Fibers</th>
</tr>
<tr>
<th>Count (Percentage)</th>
<th>Mean Density (SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td>None</td>
<td>19</td>
<td>5/19 (26.3%)</td>
<td>0.20 ± 0.12</td>
</tr>
<tr>
<td>Mild</td>
<td>25</td>
<td>11/25 (44.0%)</td>
<td>0.31 ± 0.16</td>
</tr>
<tr>
<td>Moderate</td>
<td>16</td>
<td>9/16 (56.3%)</td>
<td>0.47 ± 0.35</td>
</tr>
<tr>
<td>Severe</td>
<td>8</td>
<td>6/8 (75.0%)</td>
<td>0.47 ± 0.30</td>
</tr>
<tr>
<td>Mild, moderate, and severe combined</td>
<td>49</td>
<td>26/49 (53.1%)</td>
<td>0.40 ± 0.27</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>A multivariate analysis using the Cox regression model involving TRPV1 staining levels in stroma and/or epithelium components (adjusted by menstrual phase), density of TRPV1-positive nerve fibers in and/or surrounding endometriotic lesions, along with age, rAFS score, and cyst size, found that cyst size (<italic>P</italic> = .014) and the density of TRPV1-positive nerve fibers (<italic>P</italic> = .024) were the only 2 variables positively associated with the severity of dysmenorrhea.</p>
</sec>
<sec id="section15-1933719112443876">
<title>The Effect of Inflammatory Mediators on TRPV1 Expression in EESCs</title>
<p>We next examined the effect of PGE<sub>2</sub> and TNF-α, the 2 common inflammatory mediators in endometriosis, on TRPV1 expression in EESCs. Using cultured primary EESCs, we evaluated <italic>TRPV1</italic> gene and protein expression levels in response to stimulation with PGE<sub>2</sub> (10<sup>−8</sup> mol/L) and TNF-α (1 μmol/L), which were the normally used concentrations.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112443876">27</xref>,<xref ref-type="bibr" rid="bibr28-1933719112443876">28</xref>
</sup> The real-time RT-PCR analysis showed that, when stimulated with PGE<sub>2</sub> for 6, 12, and 24 hours, TRPV1 expression increased by 3.2-, 3.7-, and 3.1-fold in EESCs, respectively, as compared with unstimulated cells (all <italic>P</italic> values &lt;.05). When stimulated with TNF-α, TRPV1 expression was increased in a time-dependent fashion, by 1.9-, 2.9-, and 3.5-fold (<xref ref-type="fig" rid="fig5-1933719112443876">Figure 5A</xref>). Consistent with the gene expression data, the Western blot analysis showed that the incubation with PGE<sub>2</sub> and TNF-α for 24 hours resulted in significant increase in TRPV1 protein expression by 2.8- and 2.2-fold, respectively (both <italic>P</italic> values &lt;.05; <xref ref-type="fig" rid="fig5-1933719112443876">Figure 5B</xref>).</p>
<fig id="fig5-1933719112443876" position="float">
<label>Figure 5.</label>
<caption>
<p>Expression of TRPV1 in EESC stimulated by PGE<sub>2</sub> and TNF-α at different time course with real-time PCR (A) and Western blot analysis (B). <italic>P</italic> &lt; .05 as compared with the control. TRPV1 indicates transient receptor potential vanilloid 1; EESCs, ectopic endometrial stromal cells; PGE<sub>2</sub>, prostaglandin E2; TNF-α, tumor necrosis factor-α.</p>
</caption>
<graphic alternate-form-of="fig5-1933719112443876" xlink:href="10.1177_1933719112443876-fig5.tif"/>
</fig>
</sec>
<sec id="section16-1933719112443876">
<title>Effects of CAP on the Intracellular Calcium Concentration in EESCs</title>
<p>Given positive TRPV1 staining and also PGE<sub>2</sub> - and TNFα-induced TRPV1 upregulation in EESCs, we wondered whether TRPV1 in EESCs is functional or not, and we thus quantified CAP-evoked Ca<sup>2+</sup> influx in these cells. We tested whether the intracellular calcium concentration ([Ca<sup>2+</sup>]<sub>i</sub> ) can be influenced by CAP by performing fluo3/AM-based calcium imaging experiments in EESCs. Application of 1 μmol/L CAP via bath superfusion significantly reduced the fluorescence intensity in EESCs by 21.5% on average (<xref ref-type="fig" rid="fig6-1933719112443876">Figure 6A</xref>). The time to bottom was mostly within 1 minute and this effect was washed out by a rinse with balanced salt solution (<xref ref-type="fig" rid="fig6-1933719112443876">Figure 6B</xref>), without desensitization after repetitive perfusions. Over 90% of monitored cells were found to be responsive to CAP simulation, and the pretreatment with CZP (10 μmol/L) for 30 minutes abrogated this effect. CAP-induced decrease in [Ca<sup>2+</sup>]<sub>i</sub> was attenuated by high concentrations of Ca<sup>2+</sup> in external solution (data not shown). The EESC showed greater capacity of Ca<sup>2+</sup> outflux as compared with NESC when treated with the same concentration of CAP (<italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig6-1933719112443876">Figure 6C</xref>). Pretreatment with PGE<sub>2</sub> for 30 minutes significantly increased the Ca<sup>2+</sup> outflux induced by CAP in EESC (<italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig6-1933719112443876">Figure 6D</xref>).</p>
<fig id="fig6-1933719112443876" position="float">
<label>Figure 6.</label>
<caption>
<p>Calcium imaging. A, Capsaicin-induced decrease in Ca<sup>2+</sup> in EESCs. Images were taken before (left) and after (right) application of capsaicin. B, Fluorescent intensity response to consecutive application of capsaicin, washout could restore. Different curves mean different cells in different region in the same plate. C, Ectopic ESC showed greater capacity of Ca<sup>2+</sup> outflux compared with normal ESC when treated with capsaicin (ΔF/F<sub>0</sub> : The peak increase in relative fluorescent units [RFU] over the baseline fluorescence; <italic>P</italic> &lt; .05). D, Pretreatment with PGE<sub>2</sub> increases the Ca<sup>2+</sup> outflux in EESC induced by capsaicin (<italic>P</italic> &lt; .05). EESCs indicates ectopic endometrial stromal cells; CAP, capsaicin; PGE<sub>2</sub>, prostaglandin E2.</p>
</caption>
<graphic alternate-form-of="fig6-1933719112443876" xlink:href="10.1177_1933719112443876-fig6.tif"/>
</fig>
</sec>
<sec id="section17-1933719112443876">
<title>Effects of CAP on the Membrane Currents of the EESC</title>
<p>Because CAP evoked calcium reduction in EESCs, we next determined whether CAP can induce membrane currents in EESCs. To see this, we performed a whole-cell configuration patch clamp experiment. We found that incubation of EESCs with CAP (1 μmol/L) resulted in an apparent outward current (ranging from 20 pA to 170 pA, SD = 55, n = 20) in 65% of EESCs, suggesting that TRPV1 is functional in EESCs when activated by CAP. In particular, when CAP was repeatedly applied for 5 times at a duration of 3 seconds/min, there was no obvious desensitization as evidenced by the output CAP-induced currents (<xref ref-type="fig" rid="fig7-1933719112443876">Figure 7</xref>). Moreover, the outward currents induced by CAP was completely blocked by pretreatment with a TRPV1 antagonist, CZP (10 μmol/L), for 30 minutes (data not shown).</p>
<fig id="fig7-1933719112443876" position="float">
<label>Figure 7.</label>
<caption>
<p>Capsaicin at a concentration of 1μmol/L induces apparent outward currents in EESC. When capsaicin was repeatedly applied for 5 times at 3 s/min, no apparent desensitization of TRPV1 currents was found. EESCs indicates ectopic endometrial stromal cells; CAP, capsaicin.</p>
</caption>
<graphic alternate-form-of="fig7-1933719112443876" xlink:href="10.1177_1933719112443876-fig7.tif"/>
</fig>
</sec>
<sec id="section18-1933719112443876">
<title>Activation of TRPV1 Induces NO and IL-1β Release</title>
<p>To address whether activation of TRPV1 would promote the production of NO, a liquid-soluble gaseous free radical, and IL-1β, a proinflammatory cytokine, in EESC, these cells were treated with CAP (1 μmol/L), CAP (1 μmol/L) + CZP (3 μmol/L), CZP (3 μmol/L), or vehicle only, and NO and IL-1β production in the cell supernatants were quantitated. Treatment of EESC with CAP significantly increased NO and IL-1β production by 1.5- and 20-fold (both <italic>P</italic> values &lt;.001; <xref ref-type="fig" rid="fig8-1933719112443876">Figure 8</xref>), respectively, and this effect was abrogated by pretreatment with CZP (3 μmol/L; both <italic>P</italic> values &lt;.05). Capsazepine also slightly but significantly increased the NO and IL-1β release (both <italic>P</italic> values &lt;.02).</p>
<fig id="fig8-1933719112443876" position="float">
<label>Figure 8.</label>
<caption>
<p>Transient receptor potential vanilloid 1 (TRPV1) stimulation increased NO (A) and IL-1β (B) production in EESC. A: *compared with control, <italic>P</italic> &lt; .05; #compared with the capsaicin group, <italic>P</italic> &lt; .05; B: *compared with control, <italic>P</italic> &lt; .05; #compared with the capsaicin group, <italic>P</italic> &lt; .05. CAP indicates capsaicin; CZP, capsazepine; NO, nitric oxide; IL-1β, interleukin 1β; EESCs, ectopic endometrial stromal cells.</p>
</caption>
<graphic alternate-form-of="fig8-1933719112443876" xlink:href="10.1177_1933719112443876-fig8.tif"/>
</fig>
</sec>
</sec>
<sec id="section19-1933719112443876">
<title>Discussion</title>
<p>In this study, we have determined immunoreactivity of TRPV1 in both normal and ectopic endometrium and found that the TRPV1 expression in ectopic endometrium was significantly higher than that in the normal endometrium. The density of TRPV1-positive nerve fibers in ectopic endometrial implants correlates positively with the severity of dysmenorrhea in women with ovarian endometriomas. In addition, TRPV1 expression is also found to be increased significantly in cultured primary EESC when stimulated with inflammatory mediators such as PGE<sub>2</sub> and TNF-α. The latter finding appears to be consistent with the reports of increased TRPV1 protein expression following peripheral inflammation in other cell types.<sup>
<xref ref-type="bibr" rid="bibr29-1933719112443876">29</xref>
<xref ref-type="bibr" rid="bibr30-1933719112443876"/>
<xref ref-type="bibr" rid="bibr31-1933719112443876"/>–<xref ref-type="bibr" rid="bibr32-1933719112443876">32</xref>
</sup> Although these ectopic stromal cells are non-neuronal cells, they may have neurosecretory functions that are yet to be elucidated.</p>
<p>We have also demonstrated that CAP evoked Ca<sup>2+</sup> outflux and induced outward currents in EESC, and the effects can be inhibited by CZP, a TRPV1 antagonist. Although the reason as to why TRPV1 in EESCs has a Ca<sup>2+</sup> flux and a TRPV1-current direction different from that in DRG is still unclear, our results nonetheless suggest that EESCs possess functional Ca<sup>2+</sup>-permeable TRPV1 that can be activated by CAP or possibly by other pain or proinflammatory mediators in endometriotic lesions. Pretreatment with PGE<sub>2</sub> could potentiate the CAP-evoked Ca<sup>2+</sup> outflux in EESCs. The EESCs have higher Ca<sup>2+</sup> outflux as compared with NESCs when stimulated by CAP. It is possible that EESCs have greater amounts of TRPV1 or have more sensitized TRPV1 under the stimulation of inflammatory mediators. Tominaga et al found that PGE<sub>2</sub> increased or sensitized TRPV1 responses through EP<sub>1</sub> or IP receptors, respectively, predominantly in a PKC-dependent manner in both HEK293 cells expressing TRPV1 and mouse DRG neurons.<sup>
<xref ref-type="bibr" rid="bibr33-1933719112443876">33</xref>
</sup> Both PGE<sub>2</sub> -induced thermal hyperalgesia and inflammatory nociceptive responses were diminished in TRPV1-deficient mice and EP<sub>1</sub> - or IP-deficient mice. Thus, the potentiation or sensitization of TRPV1 activity through EP<sub>1</sub> or IP activation might be one important mechanism underlying the peripheral nociceptive actions of PGE<sub>2</sub>.</p>
<p>The presence of TRPV1 has been established in the dorsal root, trigeminal, nodose ganglia,<sup>
<xref ref-type="bibr" rid="bibr34-1933719112443876">34</xref>
</sup> and brain,<sup>
<xref ref-type="bibr" rid="bibr35-1933719112443876">35</xref>,<xref ref-type="bibr" rid="bibr36-1933719112443876">36</xref>
</sup> in addition to the originally reported DRG.<sup>
<xref ref-type="bibr" rid="bibr37-1933719112443876">37</xref>
</sup> Subsequently, several vanilloid receptor variants and homologues have been recognized in not only neural but also various non-neural cells, such as bronchial epithelial cells,<sup>
<xref ref-type="bibr" rid="bibr38-1933719112443876">38</xref>
</sup> keratinocytes in epidermis,<sup>
<xref ref-type="bibr" rid="bibr39-1933719112443876">39</xref>,<xref ref-type="bibr" rid="bibr40-1933719112443876">40</xref>
</sup> and urinary bladder epithelial cells.<sup>
<xref ref-type="bibr" rid="bibr41-1933719112443876">41</xref>
</sup> These observations suggest that TRPV1 is more broadly distributed than previously thought, although its functional role in these cells has yet to be elucidated.</p>
<p>It is well documented that CAP excites nociceptors by increasing the Ca<sup>2+</sup> permeability of the plasma membrane based on its effects on Ca<sup>2+</sup> influx.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112443876">17</xref>
</sup> Studies of both native and cloned TRPV1 channels have revealed several mechanisms that modulate their responsiveness to noxious stimuli. A single prolonged application of CAP, for example, leads to a gradual reduction over the course of seconds to minutes, a calcium-dependent process referred to as desensitization.<sup>
<xref ref-type="bibr" rid="bibr42-1933719112443876">42</xref>
</sup> In this study, we have demonstrated that, in contrast to sensory cells, CAP evoked Ca<sup>2+</sup> outflux and induced outward currents in EESCs. Moreover, there was no apparent desensitization of the CAP-induced currents in EESCs. These observations indicate that the TRPV1 expressing in the nonsensory EESCs may have a topological structure and function different from that in sensory neurons. Given the observed Ca<sup>2+</sup> outflux, we speculate that the intracellular Ca<sup>2+</sup> concentration within EESCs might be much higher than that in their extracellular environment, but its pathophysiological significance is yet to be elucidated. The Ca<sup>2+</sup> outflux by the concentration gradient was induced when the TRPV1 channels were activated by CAP. The calcium-dependent process referred to as desensitization may be prevented by the opposite Ca<sup>2+</sup> flux. Regardless, this somewhat novel observation suggests that TRPV1 channels in EESCs may function differently from that in sensory neurons. However, the exact mechanism of this function and its significance awaits future investigation.</p>
<p>A large body of evidence indicates that NO contributes to the processing of nociceptive signals in the spinal cord. Several animal studies<sup>
<xref ref-type="bibr" rid="bibr43-1933719112443876">43</xref>,<xref ref-type="bibr" rid="bibr44-1933719112443876">44</xref>
</sup> have consistently shown that inhibition of NO synthesis can significantly reduce both inflammatory and neuropathic pain. Poblete et al showed that low concentrations of anandamide elicit the release of NO mediated predominantly by the activation of endothelial TRPV1.<sup>
<xref ref-type="bibr" rid="bibr45-1933719112443876">45</xref>
</sup> Nitric oxide is known to be involved in inflammation and neoangiogenesis.<sup>
<xref ref-type="bibr" rid="bibr46-1933719112443876">46</xref>,<xref ref-type="bibr" rid="bibr47-1933719112443876">47</xref>
</sup> It has been shown that increased NO synthesis in endometriosis.<sup>
<xref ref-type="bibr" rid="bibr48-1933719112443876">48</xref>
<xref ref-type="bibr" rid="bibr49-1933719112443876"/>
<xref ref-type="bibr" rid="bibr50-1933719112443876"/>–<xref ref-type="bibr" rid="bibr51-1933719112443876">51</xref>
</sup> In our study, we found that stimulation of TRPV1 in EESCs increases NO production, suggesting that activated TRPV1 in endometriotic lesions may facilitate NO production, thus contributing to angiogenesis, inflammation, and increased afferent sensing of pain.</p>
<p>The increase in IL-1β production in endometriosis has long been reported.<sup>
<xref ref-type="bibr" rid="bibr52-1933719112443876">52</xref>
<xref ref-type="bibr" rid="bibr53-1933719112443876"/>–<xref ref-type="bibr" rid="bibr54-1933719112443876">54</xref>
</sup> Interleukin 1β can further induce other proinflammatory mediators such as monocyte chemoattractant protein-1 (MCP-1),<sup>
<xref ref-type="bibr" rid="bibr55-1933719112443876">55</xref>
</sup> IL-8,<sup>
<xref ref-type="bibr" rid="bibr56-1933719112443876">56</xref>
</sup> regulated upon activation normal T cell expressed and secreted, RANTES,<sup>
<xref ref-type="bibr" rid="bibr57-1933719112443876">57</xref>,<xref ref-type="bibr" rid="bibr58-1933719112443876">58</xref>
</sup> and cyclooxygenase 2 (COX-2)<sup>
<xref ref-type="bibr" rid="bibr59-1933719112443876">59</xref>
</sup> in endometriosis. The finding that TRPV1 is expressed and functional in EESCs, along with the finding that TRPV1 activation increases the IL-1β production suggests that TRPV1 activation may also contribute to the increased IL-1β production in endometriosis.</p>
<p>Taken together, the finding that stimulation with inflammatory mediators such as PGE<sub>2</sub> and TNF-α in EESC induces TRPV1 expression and that TRPV1 activation induces NO and IL-1β release seems to suggest that a feed-forward mechanism may exist in ectopic endometrium, perpetuating the increased production of proinflammatory cytokines as well as enhanced pain perception in endometriosis. Future studies are warranted to delineate the precise functions of TRPV1 activation in EESCs.</p>
<p>Although we used extrinsic agonist to stimulate TRPV1 in our in vivo studies, a variety of inflammatory mediators including prostaglandins, NGF, bradykinin, ATP, lipoxygenase products, and adenosine act via second messenger molecules such as PKA and PKC to induce TRPV1 sensitization. In addition, inflammation and hypoxia—both are present in endometriosis—are associated with tissue acidification, further potentiating TRPV1 activity. Taken together, all these factors can facilitate TRPV1 activation,<sup>
<xref ref-type="bibr" rid="bibr60-1933719112443876">60</xref>
<xref ref-type="bibr" rid="bibr61-1933719112443876"/>–<xref ref-type="bibr" rid="bibr62-1933719112443876">62</xref>
</sup> and, in turn, cause pains of various kinds in endometriosis. Therefore, TRPV1 could be functional very likely under the stimulation of inflammatory mediators, hypoxia, and some endogenous ligands such as prolactin,<sup>
<xref ref-type="bibr" rid="bibr63-1933719112443876">63</xref>
</sup> the serum level of which has been shown to be elevated in endometriosis.<sup>
<xref ref-type="bibr" rid="bibr64-1933719112443876">64</xref>
</sup>
</p>
<p>As a polymodal nocitransducer and a pain integrator that is widely expressed within pain transmitting/modulating areas of the peripheral and central nervous system, TRPV1 is activated by an array of endogenous inflammatory agents besides CAP.<sup>
<xref ref-type="bibr" rid="bibr65-1933719112443876">65</xref>
</sup> It is expressed in DRG, trigeminal, and vagal sensory ganglia in small C and Aδ sensory fibers which contain SP and CGRP, as well as co-localize with TrkA. Its activation is a key event in mechanisms of peripheral nociceptive sensitization.<sup>
<xref ref-type="bibr" rid="bibr66-1933719112443876">66</xref>
<xref ref-type="bibr" rid="bibr67-1933719112443876"/>–<xref ref-type="bibr" rid="bibr68-1933719112443876">68</xref>
</sup> Once activated, it reduces its threshold for detecting painful stimuli.<sup>
<xref ref-type="bibr" rid="bibr69-1933719112443876">69</xref>
</sup> Viewed in this lens, the elevated TRPV1-positive nerve fibers in ectopic endometrium, along with the correlation of TRPV1-positive nerve fiber density and dysmenorrhea severity as we reported here, simply suggest that TRPV1 might play a role in endometriosis-related pain.</p>
<p>Yet one limitation of this study is that we did not examine TRPV1 expression in other sites besides ectopic endometrium. One main reason for this drawback is the ethical challenge in collecting tissue samples from women who have not had children. It has been reported that in women with chronic pain, with or without endometriosis, the uteri endometrium, myometrium, isthmus, cervix, and vagina may all be reinnervated,<sup>
<xref ref-type="bibr" rid="bibr6-1933719112443876">6</xref>,<xref ref-type="bibr" rid="bibr70-1933719112443876">70</xref>
<xref ref-type="bibr" rid="bibr71-1933719112443876"/>
<xref ref-type="bibr" rid="bibr72-1933719112443876"/>–<xref ref-type="bibr" rid="bibr73-1933719112443876">73</xref>
</sup> which has been theorized to be the consequence of tissue injury resulting from difficult vaginal deliveries and/or straining during defacation<sup><xref ref-type="bibr" rid="bibr74-1933719112443876">74</xref></sup> or from microtraumatization.<sup>
<xref ref-type="bibr" rid="bibr75-1933719112443876">75</xref>
</sup> These injuries, followed by denervation and reinnervation, result in accompanying changes in the central nervous system (central sensitization),<sup>
<xref ref-type="bibr" rid="bibr74-1933719112443876">74</xref>
</sup> as seems to be the case in endometriosis.<sup>
<xref ref-type="bibr" rid="bibr76-1933719112443876">76</xref>
</sup> As central sensitization is known to be mediated by a series of changes that eventually lead to an amplified or somewhat exaggerated excitatory transmission at the synapses between primary afferent nerve fibers and second-order sensory neurons in the dorsal horns of the spinal cord,<sup>
<xref ref-type="bibr" rid="bibr77-1933719112443876">77</xref>
</sup> perhaps future animal studies may help to shed light on how tissue injury exactly promotes neurotrophic activity and through what mechanisms. Epidemiological studies may also be warranted in the future to quantify the risk, if any, of developing endometriosis in women who had difficult vaginal deliveries, extended period of straining during defacation, or other types of injuries. Currently, an outstanding challenge is to determine how these seemingly diverse aberrations cause pain of various kinds in endometriosis.</p>
<p>In sum, we have demonstrated that TRPV1-positive nerve fiber density correlates positively with the severity of dysmenorrhea in women with ovarian endometriomas. In addition, we have shown the presence of functional TRPV1 in ectopic endometrium and suggested its possible role as an initial pain sensor for noxious inflammatory stimuli in endometriosis. The increased TRPV1-positive nerve fibers may integrate various stimuli on peripheral terminals or primary sensory neurons and generate hyperalgesia in endometriosis. Upregulation and sensitization of TRPV1 in ectopic endometrium may facilitate the transmission of nociceptive information, thus contributing to the resultant pain response associated with ectopic endometrium implants of endometriosis.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-1933719112443876">
<label>Authors’ Note</label>
<p>The authors Jiangang Liu, Xishi Liu, and Kaizheng Duan contributed equally to this work.</p>
</fn>
<fn fn-type="conflict" id="fn2-1933719112443876">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1933719112443876">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported in part by grants 30872759 (SWG), 30870835, and 30821002 (YQZ) from the National Science Foundation of China, grants 2007CB512303 and 2007CB512502 from National Basic Research Program (YQZ), grants 09PJD015 and 10410700200 from the Shanghai Science and Technology Commission (SWG), grant (09-11) from the State Key Laboratory of Medical Neurobiology of Fudan University (SWG), and financial support from Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases and from the Key Specialty Project of the Ministry of Health, People’s Republic of China.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112443876">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olive</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Lindheim</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Pritts</surname>
<given-names>EA</given-names>
</name>
</person-group>. <article-title>New medical treatments for endometriosis</article-title>. <source>Best Pract Res Clin Obstet Gynaecol</source>. <year>2004</year>;<volume>18</volume>(<issue>2</issue>):<fpage>319</fpage>–<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112443876">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Endometriosis</article-title>. <source>Lancet</source>. <year>2004</year>;<volume>364</volume>(<issue>9447</issue>):<fpage>1789</fpage>–<lpage>1799</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112443876">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anaf</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>El Nakadi</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules</article-title>. <source>Hum Reprod</source>. <year>2000</year>;<volume>15</volume>(<issue>8</issue>):<fpage>1744</fpage>–<lpage>1750</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112443876">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anaf</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>El Nakadi</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis</article-title>. <source>Hum Reprod</source>. <year>2002</year>;<volume>17</volume>(<issue>7</issue>):<fpage>1895</fpage>–<lpage>1900</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112443876">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkley</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Dmitrieva</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Papka</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>Innervation of ectopic endometrium in a rat model of endometriosis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>;<volume>101</volume>(<issue>30</issue>):<fpage>11094</fpage>–<lpage>11098</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112443876">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkley</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Rapkin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Papka</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>The pains of endometriosis</article-title>. <source>Science</source>. <year>2005</year>;<volume>308</volume>(<issue>5728</issue>):<fpage>1587</fpage>–<lpage>1589</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112443876">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>Nerve fibres in peritoneal endometriosis</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>11</issue>):<fpage>3001</fpage>–<lpage>3007</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112443876">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>XF</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
</person-group>, <article-title>Zhang XM. [Protein gene product 9.5-immunoactive nerve fibers and its clinical significance in endometriotic peritoneal lesions]</article-title>. <source>Zhonghua Fu Chan Ke Za Zhi</source>. <year>2010</year>;<volume>45</volume>(<issue>4</issue>):<fpage>256</fpage>–<lpage>259</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112443876">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mechsner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kopf</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gericke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bartley</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>A pilot study to evaluate the clinical relevance of endometriosis-associated nerve fibers in peritoneal endometriotic lesions</article-title>. <source>Fertil Steril</source>. <year>2009</year>;<volume>92</volume>(<issue>6</issue>):<fpage>1856</fpage>–<lpage>1861</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112443876">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>Effects of hormonal treatment on nerve fibers in endometrium and myometrium in women with endometriosis</article-title>. <source>Fertil Steril</source>. <year>2008</year>;<volume>90</volume>(<issue>5</issue>):<fpage>1589</fpage>–<lpage>1598</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112443876">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelm Junior</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lancellotti</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Donadio</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>Nerve fibers in uterosacral ligaments of women with deep infiltrating endometriosis</article-title>. <source>J Reprod Immunol</source>. <year>2008</year>;<volume>79</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112443876">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dubinovsky</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>Hyperinnervation in intestinal deep infiltrating endometriosis</article-title>. <source>J Minim Invasive Gynecol</source>. <year>2009</year>;<volume>16</volume>(<issue>6</issue>):<fpage>713</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112443876">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>Rich innervation of deep infiltrating endometriosis</article-title>. <source>Hum Reprod</source>. <year>2009</year>;<volume>24</volume>(<issue>4</issue>):<fpage>827</fpage>–<lpage>834</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112443876">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Nerve fibers in ovarian endometriomas</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>94</volume>(<issue>5</issue>):<fpage>1944</fpage>–<lpage>1947</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112443876">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis</article-title>. <source>Hum Reprod</source>. <year>2010</year>;<volume>25</volume>(<issue>2</issue>):<fpage>392</fpage>–<lpage>397</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112443876">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szallasi</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Vanilloid (capsaicin) receptors in health and disease</article-title>. <source>Am J Clin Pathol</source>. <year>2002</year>;<volume>118</volume>(<issue>1</issue>):<fpage>110</fpage>–<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112443876">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caterina</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Julius</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The capsaicin receptor: a heat-activated ion channel in the pain pathway</article-title>. <source>Nature</source>. <year>1997</year>;<volume>389</volume>(<issue>6653</issue>):<fpage>816</fpage>–<lpage>824</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112443876">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>A</given-names>
</name>
<name>
<surname>DeFelice</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eyde</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents</article-title>. <source>Mol Pain</source>. <year>2011</year>;<volume>7</volume>(1):<fpage>4</fpage>.</citation>
</ref>
<ref id="bibr19-1933719112443876">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocha</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ribeiro da Silva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Candido Dos Reis</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Poli-Neto</surname>
<given-names>OB</given-names>
</name>
</person-group>. <article-title>TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain</article-title>. <source>Reprod Sci</source>. <year>2011</year>;<volume>18</volume>(<issue>6</issue>):<fpage>511</fpage>–<lpage>515</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112443876">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice</article-title>. <source>Hum Reprod</source>. <year>2010</year>;<volume>25</volume>(<issue>4</issue>):<fpage>1014</fpage>–<lpage>1025</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112443876">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis</article-title>. <source>Am J Obstet Gynecol</source>. <year>2010</year>;<volume>202</volume>(<issue>4</issue>):346. <fpage>e341</fpage>–<lpage>e348</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112443876">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang-Tilz</surname>
<given-names>YTC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tilz</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Stefan</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy</article-title>. <source>Epilepsia</source>. <year>2006</year>;<volume>47</volume>(<issue>2</issue>):<fpage>233</fpage>–<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112443876">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weidner</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors</article-title>. <source>Breast Cancer Res Treat</source>. <year>1995</year>;<volume>36</volume>(<issue>2</issue>):<fpage>169</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112443876">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockwood</surname>
<given-names>CJNY</given-names>
</name>
<name>
<surname>Guller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krikun</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1993</year>;<volume>76</volume>(<issue>1</issue>):<fpage>231</fpage>–<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112443876">
<label>25</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Kalbfleisch</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Prentice</surname>
<given-names>RL</given-names>
</name>
</person-group>. <source>The Statistical Analysis of Failure Time Data</source>. Edited by <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Wiley</publisher-name>; <year>1980</year>.</citation>
</ref>
<ref id="bibr26-1933719112443876">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inhaka</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gentleman</surname>
<given-names>RR</given-names>
</name>
</person-group>. <article-title>R: a language for data analysis and graphics</article-title>. <source>J Comput Graph Statist</source>. <year>1996</year>;<volume>5</volume>(3):<fpage>1923</fpage>–<lpage>1927</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112443876">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Higashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Togashi</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins</article-title>. <source>Molecular Pain</source> <year>2005</year>;<volume>1</volume>:<fpage>3</fpage>. doi:10.1186/1744-8069-1-3</citation>
</ref>
<ref id="bibr28-1933719112443876">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henselleka</surname>
<given-names>SBP</given-names>
</name>
<name>
<surname>Schaiblea</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Bräuerb</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bancheta</surname>
<given-names>GS</given-names>
</name>
</person-group>. <article-title>The cytokine TNFα increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation</article-title>. <source>Mol Cell Neurosci</source>. <year>2007</year>;<volume>36</volume>(<issue>3</issue>):<fpage>381</fpage>–<lpage>391</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112443876">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlton</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Coggeshall</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization</article-title>. <source>Neurosci Lett</source>. <year>2001</year>;<volume>310</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112443876">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yiangou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Facer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dyer</surname>
<given-names>NHC</given-names>
</name>
<etal/>
</person-group> <article-title>Vanilloid receptor 1 immunoreactivity in inflamed human bowel</article-title>. <source>Lancet</source>. <year>2001</year>;<volume>357</volume>(<issue>9265</issue>):<fpage>1338</fpage>–<lpage>1339</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112443876">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Samad</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>SX</given-names>
</name>
<name>
<surname>Schmoll</surname>
<given-names>R</given-names>
</name>
</person-group>, <article-title>Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia</article-title>. <source>Neuron</source>. <year>2002</year>;<volume>36</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112443876">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaya</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Oh-Hashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Naruse</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons</article-title>. <source>Brain Res</source>. <year>2003</year>;<volume>963</volume>(<issue>1-2</issue>):<fpage>190</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112443876">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Structure and function of TRPV1</article-title>. <source>Pflugers Arch</source>. <year>2005</year>;<volume>451</volume>(<issue>1</issue>):<fpage>143</fpage>–<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112443876">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szallasi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blumberg</surname>
<given-names>PM</given-names>
</name>
</person-group>. <article-title>Vanilloid (capsaicin) receptors and mechanisms</article-title>. <source>Pharmacol Rev</source>. <year>1999</year>;<volume>51</volume>(<issue>2</issue>):<fpage>159</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112443876">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tohda</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuraishi</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus</article-title>. <source>Neuroreport</source>. <year>1998</year>;<volume>9</volume>(<issue>9</issue>):<fpage>2045</fpage>–<lpage>2048</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112443876">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mezey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>ZE</given-names>
</name>
<name>
<surname>Cortright</surname>
<given-names>DN</given-names>
</name>
<etal/>
</person-group> <article-title>Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2000</year>;<volume>97</volume>(<issue>7</issue>):<fpage>3655</fpage>–<lpage>3660</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112443876">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caterina</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Julius</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The capsaicin receptor: a heat-activated ion channel in the pain pathway</article-title>. <source>Nature</source>. <year>1997</year>;<volume>389</volume>(<issue>6653</issue>):<fpage>816</fpage>–<lpage>824</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112443876">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veronesi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Oortgiesen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>RB</given-names>
</name>
</person-group>. <article-title>Particulate matter initiates inflammatory cytokine release by activation of capsaicin and acid receptors in a human bronchial epithelial cell line</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>1999</year>;<volume>154</volume>(<issue>1</issue>):<fpage>106</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr39-1933719112443876">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denda</surname>
<given-names>MFS</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Denda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tomitaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Immunoreactivity of VR1 on epidermal keratinocyte of human skin</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2001</year>;<volume>285</volume>(<issue>5</issue>):<fpage>1250</fpage>–<lpage>1252</lpage>.</citation>
</ref>
<ref id="bibr40-1933719112443876">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Koizumi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fuziwara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denda</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Functional vanilloid receptors in cultured normal human epidermal keratinocytes</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2002</year>;<volume>291</volume>(<issue>1</issue>):<fpage>124</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr41-1933719112443876">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birder</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>de Groat</surname>
<given-names>WC</given-names>
</name>
<etal/>
</person-group> <article-title>Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>23</issue>):<fpage>13396</fpage>–<lpage>13401</lpage>.</citation>
</ref>
<ref id="bibr42-1933719112443876">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Julius</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>TRP channel structural biology: new roles for an old fold</article-title>. <source>Neuron</source>. <year>2007</year>;<volume>54</volume>(<issue>6</issue>):<fpage>847</fpage>–<lpage>850</lpage>.</citation>
</ref>
<ref id="bibr43-1933719112443876">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meller</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Gebhart</surname>
<given-names>GF</given-names>
</name>
</person-group>. <article-title>Nitric-Oxide(NO) and nociceptive processing in the spinal-cord</article-title>. <source>Pain</source>. <year>1993</year>;<volume>52</volume>(<issue>2</issue>):<fpage>127</fpage>–<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr44-1933719112443876">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Cizkova</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The role of nitric oxide in nociception</article-title>. <source>Curr Rev Pain</source>. <year>2000</year>;<volume>4</volume>(<issue>6</issue>):<fpage>459</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr45-1933719112443876">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poblete</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Orliac</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Briones</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Adler-Graschinsky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Huidobro-Toro</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed</article-title>. <source>J Physiol London</source>. <year>2005</year>;<volume>568</volume>(<issue>pt 2</issue>):<fpage>539</fpage>–<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr46-1933719112443876">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moncada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Higgs</surname>
<given-names>EA</given-names>
</name>
</person-group>. <article-title>Nitric oxide: physiology, pathophysiology, and pharmacology</article-title>. <source>Pharmacol Rev</source>. <year>1991</year>;<volume>43</volume>(<issue>2</issue>):<fpage>109</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr47-1933719112443876">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moncada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Higgs</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>The L-arginine-nitric oxide pathway</article-title>. <source>N Engl J Med</source>. <year>1993</year>;<volume>329</volume>(<issue>27</issue>):<fpage>2002</fpage>–<lpage>2012</lpage>.</citation>
</ref>
<ref id="bibr48-1933719112443876">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Increased nitric oxide in peritoneal fluid from women with idiopathic infertility and endometriosis</article-title>. <source>J Reprod Med</source>. <year>2001</year>;<volume>46</volume>(<issue>10</issue>):<fpage>887</fpage>–<lpage>891</lpage>.</citation>
</ref>
<ref id="bibr49-1933719112443876">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osborn</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Haney</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Misukonis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>JB</given-names>
</name>
</person-group>. <article-title>Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility</article-title>. <source>Fertil Steril</source>. <year>2002</year>;<volume>77</volume>(<issue>1</issue>):<fpage>46</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr50-1933719112443876">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>HN</given-names>
</name>
</person-group>. <article-title>Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis</article-title>. <source>Hum Reprod</source>. <year>2003</year>;<volume>18</volume>(<issue>12</issue>):<fpage>2668</fpage>–<lpage>2671</lpage>.</citation>
</ref>
<ref id="bibr51-1933719112443876">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goteri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lucarini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zizzi</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts</article-title>. <source>Virchows Arch</source>. <year>2010</year>;<volume>456</volume>(<issue>6</issue>):<fpage>703</fpage>–<lpage>710</lpage>.</citation>
</ref>
<ref id="bibr52-1933719112443876">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sawairi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tamaya</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis</article-title>. <source>Fertil Steril</source>. <year>1992</year>;<volume>57</volume>(<issue>3</issue>):<fpage>535</fpage>–<lpage>542</lpage>.</citation>
</ref>
<ref id="bibr53-1933719112443876">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergqvist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bruse</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Carlberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carlstrom</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium</article-title>. <source>Fertil Steril</source>. <year>2001</year>;<volume>75</volume>(<issue>3</issue>):<fpage>489</fpage>–<lpage>495</lpage>.</citation>
</ref>
<ref id="bibr54-1933719112443876">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheong</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Shelton</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group> <article-title>IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions</article-title>. <source>Hum Reprod</source>. <year>2002</year>;<volume>17</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr55-1933719112443876">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akoum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jolicoeur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2000</year>;<volume>85</volume>(<issue>2</issue>):<fpage>896</fpage>–<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr56-1933719112443876">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akoum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lawson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McColl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Villeneuve</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro</article-title>. <source>Mol Hum Reprod</source>. <year>2001</year>;<volume>7</volume>(<issue>9</issue>):<fpage>859</fpage>–<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr57-1933719112443876">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebovic</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Martini</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RN</given-names>
</name>
</person-group>. <article-title>IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2001</year>;<volume>86</volume>(<issue>10</issue>):<fpage>4759</fpage>–<lpage>4764</lpage>.</citation>
</ref>
<ref id="bibr58-1933719112443876">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akoum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lemay</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maheux</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2002</year>;<volume>87</volume>(<issue>12</issue>):<fpage>5785</fpage>–<lpage>5792</lpage>.</citation>
</ref>
<ref id="bibr59-1933719112443876">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2005</year>;<volume>90</volume>(<issue>1</issue>):<fpage>286</fpage>–<lpage>295</lpage>.</citation>
</ref>
<ref id="bibr60-1933719112443876">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugiura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Katsuya</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mizumura</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1</article-title>. <source>J Neurophysiol</source>. <year>2002</year>;<volume>88</volume>(<issue>1</issue>):<fpage>544</fpage>–<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr61-1933719112443876">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masu</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>12</issue>):<fpage>6951</fpage>–<lpage>6956</lpage>.</citation>
</ref>
<ref id="bibr62-1933719112443876">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ristoiu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Shibasaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC</article-title>. <source>Pain</source>. <year>2011</year>;<volume>152</volume>(<issue>4</issue>):<fpage>936</fpage>–<lpage>945</lpage>.</citation>
</ref>
<ref id="bibr63-1933719112443876">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diogenes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Patwardhan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Jeske</surname>
<given-names>NA</given-names>
</name>
<etal/>
</person-group> <article-title>Prolactin modulates TRPV1 in female rat trigeminal sensory neurons</article-title>. <source>J Neurosci</source>. <year>2006</year>;<volume>26</volume>(<issue>31</issue>):<fpage>8126</fpage>–<lpage>8136</lpage>.</citation>
</ref>
<ref id="bibr64-1933719112443876">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Rosa e Silva</surname>
<given-names>AA</given-names>
</name>
</person-group>. <article-title>Prolactin and cortisol levels in women with endometriosis</article-title>. <source>Braz J Med Biol Res</source>. <year>2006</year>;<volume>39</volume>(<issue>8</issue>):<fpage>1121</fpage>–<lpage>1127</lpage>.</citation>
</ref>
<ref id="bibr65-1933719112443876">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordt</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>McKemy</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Julius</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Lessons from peppers and peppermint: the molecular logic of thermosensation</article-title>. <source>Curr Opin Neurobiol</source>. <year>2003</year>;<volume>13</volume>(<issue>4</issue>):<fpage>487</fpage>–<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr66-1933719112443876">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hucho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Signaling pathways in sensitization: toward a nociceptor cell biology</article-title>. <source>Neuron</source>. <year>2007</year>;<volume>55</volume>(<issue>3</issue>):<fpage>365</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr67-1933719112443876">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stucky</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Dubin</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Jeske</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Malin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>McKemy</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Story</surname>
<given-names>GM</given-names>
</name>
</person-group>. <article-title>Roles of transient receptor potential channels in pain</article-title>. <source>Brain Res Rev</source>. <year>2009</year>;<volume>60</volume>(<issue>1</issue>):<fpage>2</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr68-1933719112443876">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Studer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McNaughton</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Modulation of single-channel properties of TRPV1 by phosphorylation</article-title>. <source>J Physiol</source>. <year>2010</year>;<volume>588</volume>(<issue>pt 19</issue>):<fpage>3743</fpage>–<lpage>3756</lpage>.</citation>
</ref>
<ref id="bibr69-1933719112443876">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palazzo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Luongo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>de Novellis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marabese</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Maione</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Transient receptor potential vanilloid type 1 and pain development</article-title>. <source>Curr Opin Pharmacol</source>. <year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr70-1933719112443876">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atwal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>du Plessis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Slade</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Uterine innervation after hysterectomy for chronic pelvic pain with, and without, endometriosis</article-title>. <source>Am J Obstet Gynecol</source>. <year>2005</year>;<volume>193</volume>(<issue>5</issue>):<fpage>1650</fpage>–<lpage>1655</lpage>.</citation>
</ref>
<ref id="bibr71-1933719112443876">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McAllister</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>McGinty</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Resuehr</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berkley</surname>
<given-names>KJ</given-names>
</name>
</person-group>. <article-title>Endometriosis-induced vaginal hyperalgesia in the rat: role of the ectopic growths and their innervation</article-title>. <source>Pain</source>. <year>2009</year>;<volume>147</volume>(<issue>1-3</issue>):<fpage>255</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr72-1933719112443876">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis</article-title>. <source>Fertil Steril</source>. <year>2007</year>;<volume>88</volume>(<issue>4</issue>):<fpage>795</fpage>–<lpage>803</lpage>.</citation>
</ref>
<ref id="bibr73-1933719112443876">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokushige</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Markham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>IS</given-names>
</name>
</person-group>. <article-title>High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis</article-title>. <source>Hum Reprod</source>. <year>2006</year>;<volume>21</volume>(<issue>3</issue>):<fpage>782</fpage>–<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr74-1933719112443876">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Endometriosis: the consequence of uterine denervation-reinnervation</article-title>. <source>Arch Gynecol Obstet</source>. <year>2011</year>;<volume>284</volume>(<issue>6</issue>):<fpage>1423</fpage>–<lpage>1429</lpage>.</citation>
</ref>
<ref id="bibr75-1933719112443876">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leyendecker</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wildt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mall</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>The pathophysiology of endometriosis and adenomyosis: tissue injury and repair</article-title>. <source>Arch Gynecol Obstet</source>. <year>2009</year>;<volume>280</volume>(<issue>4</issue>):<fpage>529</fpage>–<lpage>538</lpage>.</citation>
</ref>
<ref id="bibr76-1933719112443876">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery</article-title>. <source>Reprod Sci</source>. <year>2010</year>;<volume>17</volume>(<issue>12</issue>):<fpage>1099</fpage>–<lpage>1111</lpage>.</citation>
</ref>
<ref id="bibr77-1933719112443876">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tominaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masu</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>12</issue>):<fpage>6951</fpage>–<lpage>6956</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>